Sanjiv Lal spent twenty years building pharmaceutical, diagnostic, and laboratory companies. Then at forty, he became the patient, and the system he helped build told him to manage his decline. In this episode, Brent talks with Sanjiv about what happened next, and about the peptide boom nobody is explaining honestly. They get into what peptides actually are, why the FDA is reconsidering its restrictions on roughly nineteen of them, and what's really inside the vials people buy online.
You'll hear about: - What it's like to become a patient inside the industry you built your career in - Why the future of regenerative medicine might be the signals cells send, not the cells themselves - Which peptides have real evidence and which ones people are taking on faith - The honest risk of gray-market "research use only" compounds - How a clinic decides what goes on its menu, and the red flags to walk out on - What to do about all of this on a normal budget
Guest: Sanjiv Lal, pharmaceutical scientist, co-founder of RegenTherapy and Cell Factors, and Chief Innovation Officer at Beverly Hills Rejuvenation Center.
Disclaimer: This podcast is for educational purposes only and is not personal medical advice, diagnosis, or treatment. Nothing in this conversation creates a clinician-patient relationship. Always work with your own licensed clinician before making decisions about your health.
If this helped you think differently, share it with one person in their 40s or 50s who needs to hear it. Subscribe so you never miss a loop.
Subscribe for weekly longevity, biohacking, and health optimization content.
Podden och tillhörande omslagsbild på den här sidan tillhör
Brent Wallace. Innehållet i podden är skapat av Brent Wallace och inte av,
eller tillsammans med, Poddtoppen.
